EMIGH JAMES F 4

4 · ACURA PHARMACEUTICALS, INC · Filed Dec 17, 2018

Form 4

Period: 2018-12-11

VP Marketing & Administration

Transactions

Award
Restricted Stock Unit
2018-12-11+60,000→ 60,000 total
Exercise: $0.01→ Common Stock (60,000 underlying)
Award
Stock Option
2018-12-11+20,000→ 20,000 total
Exercise: $0.15From: 2019-12-11Exp: 2023-12-11→ Common Stock (20,000 underlying)

Footnotes (7)

[F1]Awarded under the Acura Pharmaceuticals Inc. 2017 Restricted Stock Unit Award Plan (the "Plan").
[F2]Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
[F3]100% of Restricted Stock Units vest on December 11, 2019 or earlier if Reporting Person's service as an employee of Issuer is terminated by Issuer without Cause (as defined in the Plan) or due to Reporting Person's death or Disability (as defined in the Plan) or a qualifying change of control occurs. Distributions in respect of vested Restricted Stock Units will be made in three equal installments on the first business day of each of January 2021, 2022, and 2023 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code.
[F4]Not Applicable.
[F5]Awarded under the Acura Pharmaceuticals Inc. 2016 Stock Option Plan.
[F6]Exercise price is closing price of Issuer's common stock on December 11, 2018.
[F7]Option vesting and exercisability is accelerated upon a qualifying change of control.

Documents

1 file